Atlas Trials

Athenex, Inc.

21 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Athenex, Inc.

RecordFirmDate
Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies (NCT05487651)Athenex, Inc.2022-10-01
Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors (NCT04878484)Athenex, Inc.2021-08-11
A Phase I Open-label Study for Subjects With Advanced Malignancies (NCT04136834)Athenex, Inc.2021-04-21
The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol (NCT03892018)Athenex, Inc.2019-08-05
A PK Study of Oraxol in Breast Cancer Patients (NCT04993040)Athenex, Inc.2019-04-22
A Study of Oraxol in Subjects With Cutaneous Angiosarcoma (NCT03544567)Athenex, Inc.2018-12-21
Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors (NCT03588039)Athenex, Inc.2018-10-25
Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis (NCT03575780)Athenex, Inc.2018-09-07
Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies (NCT03987685)Athenex, Inc.2018-07-19

Track Athenex, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.